ReviewOncoTargets and therapy2016

Molecularly targeted therapy for the treatment of head and neck cancer: a review of the ErbB family inhibitors.

Assuntina G Sacco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.